MITSUBISHI INTERNATIONAL CORP 4
4 · MEMORY PHARMACEUTICALS CORP · Filed Apr 12, 2004
Insider Transaction Report
Form 4
MITSUBISHI CORP
Other
Transactions
- Conversion
Common Stock
2004-04-08+465,117→ 465,117 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−1,395,351→ 0 total(indirect: See Footnote)→ Common Stock (465,117 underlying)
Footnotes (4)
- [F1]The shares of Series D Convertible Preferred Stock reported consist of shares held of record by each of the entities listed below. Mitsubishi Corporation, Mitsubishi International Corporation, and MC Life Science Ventures, Inc. (formerly known first as CZ Venture Operations, Inc., then as CZ Specialty Chemicals, Inc.); each own 465,117 shares of Series D Convertible Preferred Stock. Upon conversion, Mitsubishi Corporation, Mitsubishi International Corporation, and MC Life Science Ventures, Inc. each own 155,039 shares of common stock. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F2]Each share of Series D Convertible Preferred Stock converted into .3333 shares of Common Stock.
- [F3]These securities automatically converted into Common Stock upon the closing of the issuer?s initial public offering.
- [F4]These securities do not have an expiration date.